CureVac (CVAC) Return on Sales (2019 - 2025)
Historic Return on Sales for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to 6.32%.
- CureVac's Return on Sales rose 55000.0% to 6.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.42%, marking a year-over-year increase of 30900.0%. This contributed to the annual value of 0.3% for FY2024, which is 51400.0% up from last year.
- According to the latest figures from Q3 2025, CureVac's Return on Sales is 6.32%, which was up 55000.0% from 48.49% recorded in Q2 2025.
- In the past 5 years, CureVac's Return on Sales ranged from a high of 58.32% in Q1 2025 and a low of 48.49% during Q2 2025
- Moreover, its 5-year median value for Return on Sales was 4.84% (2024), whereas its average is 3.46%.
- Examining YoY changes over the last 5 years, CureVac's Return on Sales showed a top increase of 639200bps in 2025 and a maximum decrease of -436500bps in 2025.
- CureVac's Return on Sales (Quarter) stood at 0.13% in 2021, then plummeted by -8034bps to 10.98% in 2022, then soared by 65bps to 3.84% in 2023, then plummeted by -83bps to 7.02% in 2024, then skyrocketed by 190bps to 6.32% in 2025.
- Its Return on Sales stands at 6.32% for Q3 2025, versus 48.49% for Q2 2025 and 58.32% for Q1 2025.